Search

everythinglearnresearchcommunity

for

Search:↓

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Tadalafil and Finasteride may help treat aggressive melanoma.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Gefitinib can cause rare scarring hair loss.

Polymeric nanoparticles show promise for treating skin diseases.

Targeted cancer therapies often cause serious skin problems that need careful management.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

PDGFA/AKT signaling is important for the growth and maintenance of certain skin fat cells.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Oncogenic melanocyte stem cells can develop into melanoma similar to human cases.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Trichoscopy is useful for diagnosing and monitoring hair and scalp conditions over time.